Voyageur Pharmaceuticals Ltd. filed its Annual on Mar 30, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | -12.50% |
|
-17.65% | -6.67% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 7.1M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- VM Stock
- News Voyageur Pharmaceuticals Ltd.
- Voyageur Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt